Speakers
Co-Chairs

Heidi Gertner
Partner
Hogan Lovells LLP

Liping Wu
MD, PhD, RAC, Global Regulatory Affairs Manager
Kenvue
Distinguished Faculty

Ann Begley
Partner
Wiley Rein LLP

Dan Brum
PharmD, MBA, BCPS, Chief of Project Management, Office of Nonprescription Drugs
Food and Drug Administration (FDA)

Cathy Burgess
Partner
Alston & Bird LLP

Ludjane Carvalho
Director Regulatory Affairs
Colgate-Palmolive

Kellie Combs
Partner
Ropes & Gray

Daniel R. Dwyer
Partner
Kleinfeld Kaplan & Becker LLP

Kyle Y. Faget
Partner
Foley & Lardner LLP

Shoshana Golden
Attorney
ArentFox Schiff LLP

Monica C. Groat
Counsel
Latham & Watkins LLP

David Grob
Vice President, Regulatory Affairs
Pocket Naloxone Company

Todd Halpern
Assistant General Counsel
Haleon

Todd Harrison
Partner
Venable LLP

Bethany J. Hills
Vice Chair FDA Regulatory Practice
DLA Piper LLP (US)

David Horowitz
Partner
Hogan Lovells US LLP

John F. Johnson III
Senior Counsel
Shook, Hardy & Bacon L.L.P

Kristen Klesh
Partner
Loeb & Loeb LLP

Deborah Livornese
Partner
Hyman, Phelps & McNamara P.C.

Stephen McConnell
Partner
Reed Smith LLP

Diane McEnroe
Partner
Sidley Austin LLP

Meghan G. Walters Price
Director and Assistant General Counsel
The Procter & Gamble Company

James Prochnow
Partner
Greenberg Traurig LLP

Nikki Reeves
Partner
King & Spalding LLP

Amy Repolgle
Director, Rx-to-OTC Switch
Bayer

Paul D. Rubin
Partner
Debevoise & Plimpton LLP

Jennifer Santos
Attorney
National Advertising Division (NAD)

May Smith
Marketing Director, Rx to OTC Switch
Haleon

Andrew Soukup
Partner
Covington & Burling LLP

Frederick A. Stearns
Partner
Keller and Heckman LLP
